Raft Of MHRA Guidance And Govt Trade Advice Greet UK Medtechs At Start Of Year
Preparations for Brexit and the UK’s new medtech regulatory system kept the MHRA busy over the holiday period and into the new year.
You may also be interested in...
Three weeks remain for the UK to secure an EU free trade deal, and the transition period will not be extended, the UK government has again underlined.
There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.